As researchers around the world work to find a vaccine for COVID-19, a team at the University of Waterloo is exploring the potential of a DNA-based vaccine that can be delivered through a nasal spray.
The goal is to have the vaccine target tissues in the nasal cavity and lower respiratory tract, causing them to produce a virus-like particle and stimulate an immune response.
The project is a collaboration between researchers in pharmacy and chemical engineering in order to design the nanomedication that will be delivered by the nasal spray, and construct and purify the virus-like particle.
For more information, visit the University of Waterloo.
